Par Drugs & Chemical

84.98
+0.05
(0.06%)
Market Cap
104.56 Cr
EPS
11.78
PE Ratio
6.77
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
348.45
52 Week Low
84.93
PB Ratio
1.08
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,684.60
#1 4,04,191.97
35.30
#1 49,887.20
12.06
#1 9,648
13.77
54.74
5,548.00
1,47,281.97
74.15
8,184.00
0.89
1,600
#1 64.53
50.68
1,446.15
1,16,793.23
23.34
26,520.70
14.17
4,155
47.38
42.46
3,182.65
1,07,715.34
58.79
10,785.70
11.59
1,656
13.54
59.06
2,425.00
1,00,050.29
48.97
10,615.60
19.57
1,942
-16.38
57.16
1,152.55
96,175.15
#1 17.77
28,905.40
12.36
5,578
1.69
43.23
1,951.00
89,071.14
32.25
20,141.50
#1 19.94
1,936
38.82
48.77
874.75
88,020.32
19.66
19,831.50
13.82
3,831
29.92
41.50
1,136.10
65,984.87
19.11
29,559.20
17.55
3,169
-10.04
52.98
30,564.00
64,946.37
48.94
6,097.20
10.80
1,201
16.01
56.63
Growth Rate
Revenue Growth
-0.10 %
Net Income Growth
28.32 %
Cash Flow Change
51.35 %
ROE
6.41 %
ROCE
8.32 %
EBITDA Margin (Avg.)
25.13 %

Yearly Financial Results

Annual Financials
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
49
42
46
56
61
75
96
96
103
Expenses
40
34
38
46
45
59
78
73
78
EBITDA
9
8
8
10
16
16
18
23
25
Operating Profit %
18 %
19 %
18 %
17 %
26 %
22 %
19 %
24 %
21 %
Depreciation
3
3
3
3
3
3
3
3
4
Interest
3
2
2
1
1
1
0
0
0
Profit Before Tax
3
3
3
6
15
13
15
20
21
Tax
2
1
1
1
3
4
4
5
5
Net Profit
2
2
3
5
12
9
11
15
15
EPS in ₹
6.50
5.64
5.60
7.75
18.87
7.49
9.21
11.78
12.50

Balance Sheet

Balance Sheet
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
56
54
51
60
76
79
89
102
Fixed Assets
42
39
36
34
30
34
38
41
Current Assets
14
14
14
24
41
44
49
60
Capital Work in Progress
0
0
0
1
5
0
0
0
Investments
0
0
0
0
0
0
0
0
Other Assets
15
15
15
25
42
44
50
60
Total Liabilities
56
54
51
60
76
79
89
102
Current Liabilities
20
17
13
11
16
15
14
12
Non Current Liabilities
17
16
10
9
8
4
4
4
Total Equity
20
21
29
41
52
60
71
86
Reserve & Surplus
11
13
25
35
46
48
59
73
Share Capital
9
9
5
6
6
12
12
12

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
1
-1
0
0
7
14
-5
6
14
Investing Activities
-0
-0
-2
-1
-0
-2
0
-3
-7
-6
Operating Activities
9
7
9
4
2
8
12
8
13
20
Financing Activities
-9
-6
-8
-4
-2
1
2
-10
0
0

Share Holding

% Holding
Mar 2021
Apr 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
73.86 %
73.86 %
73.86 %
73.98 %
74.21 %
74.21 %
74.21 %
74.21 %
74.21 %
74.21 %
74.21 %
74.21 %
74.21 %
74.21 %
73.37 %
73.37 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.06 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
24.02 %
23.73 %
20.92 %
21.55 %
21.48 %
21.29 %
21.55 %
21.98 %
22.05 %
21.85 %
21.40 %
21.23 %
20.46 %
20.09 %
19.42 %
22.86 %
Others
2.11 %
2.41 %
5.22 %
4.47 %
4.31 %
4.50 %
4.24 %
3.81 %
3.74 %
3.94 %
4.39 %
4.50 %
5.34 %
5.71 %
7.21 %
3.77 %
No of Share Holders
289
302
491
3,514
4,034
4,262
5,071
5,676
5,585
5,686
5,902
7,020
7,403
8,022
8,757
17,199

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Technical Indicators

RSI(14)
Oversold
19.28
ATR(14)
Volatile
6.53
STOCH(9,6)
Oversold
18.31
STOCH RSI(14)
Neutral
30.57
MACD(12,26)
Bullish
2.13
ADX(14)
Very Strong Trend
53.04
UO(9)
Bullish
26.59
ROC(12)
Downtrend And Accelerating
-16.09
WillR(14)
Oversold
-100.00